EUVIMEDEUVIMED entdecken
Crossref

Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring

Yuki Matsumura-Tojima, Tomoya Sugita, Yusuke Tanizaki, Makiko Tani, Ayumi Wada, Takeshi Kondo

Internal Medicine · 2026

DOI: 10.2169/internalmedicine.7357-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine, 2026. Verfasst von Yuki Matsumura-Tojima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Tokushima Red Cross Hospital, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Type B insulin resistance syndromeautoimmune diseasecontinuous glucose monitoringcyclosporineglucocorticoid therapyinsulin receptor antibody

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, Tokushima Red Cross Hospital, Japan.

Zitieren

APA

Matsumura-Tojima, Y., Sugita, T., Tanizaki, Y., Tani, M., Wada, A., & Kondo, T. (2026). Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring. Internal Medicine. https://doi.org/10.2169/internalmedicine.7357-26

Vancouver

Matsumura-Tojima Y, Sugita T, Tanizaki Y, Tani M, Wada A, Kondo T. Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring. Internal Medicine. 2026. doi:10.2169/internalmedicine.7357-26

BibTeX
@article{MatsumuraTojima2026,
  author = {Matsumura-Tojima, Yuki and Sugita, Tomoya and Tanizaki, Yusuke and Tani, Makiko and Wada, Ayumi and Kondo, Takeshi},
  title = {Early Remission of Type B Insulin Resistance Syndrome Achieved by Glucocorticoid-based Immunosuppressive Therapy and Visualized by Intermittently Scanned Continuous Glucose Monitoring},
  journal = {Internal Medicine},
  year = {2026},
  doi = {10.2169/internalmedicine.7357-26}
}
Kostenlos starten →